Narnolia

Narnolia

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE512.25-8.2 (-1.58 %)
PREV CLOSE ( ) 520.45
OPEN PRICE ( ) 520.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 135041
TODAY'S LOW / HIGH ( )508.50 524.00
52 WK LOW / HIGH ( )168 572.7
NSE512.10-8.3 (-1.59 %)
PREV CLOSE( ) 520.40
OPEN PRICE ( ) 521.90
BID PRICE (QTY) 512.10 (823)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1849462
TODAY'S LOW / HIGH( ) 508.05 524.75
52 WK LOW / HIGH ( )161.65 573.05
Select year
ParticularsMar2020Mar2019Mar2018Mar2017Mar2016
Operational & Financial Ratios
   Earnings Per Share (Rs)27.5032.7828.4939.3026.34
   CEPS(Rs)42.2844.3339.1948.6634.64
   DPS(Rs)2.502.002.002.002.00
   Book NAV/Share(Rs)214.65198.27182.62159.16128.59
   Tax Rate(%)29.2028.8828.1825.6628.83
Margin Ratios
   Core EBITDA Margin(%)15.9616.0717.7522.1718.79
   EBIT Margin(%)13.8516.5815.4318.8215.99
   Pre Tax Margin(%)10.3013.1812.3016.2413.65
   PAT Margin (%)7.299.388.8312.079.71
   Cash Profit Margin (%)11.2112.6812.1514.9512.78
Performance Ratios
   ROA(%)6.177.987.4011.338.52
   ROE(%)13.3217.2116.6727.3127.46
   ROCE(%)14.0416.4714.7720.5418.53
   Asset Turnover(x)0.850.850.840.940.88
   Sales/Fixed Asset(x)1.441.661.802.031.96
   Working Capital/Sales(x)3.973.692.462.204.02
Efficiency Ratios
   Fixed Capital/Sales(x)0.700.600.560.490.51
   Receivable days78.9583.7394.9597.29119.39
   Inventory Days75.2579.2283.5973.6567.68
   Payable days98.4497.4396.28101.59117.03
Valuation Parameters
   PER(x)7.4919.6918.5121.8330.15
   PCE(x)4.8714.5613.4517.6322.93
   Price/Book(x)0.963.262.895.396.18
   Yield(%)1.210.310.380.230.25
   EV/Net Sales(x)0.902.202.013.073.38
   EV/Core EBITDA(x)5.1512.1110.7113.4417.53
   EV/EBIT(x)6.5013.2913.0116.1220.89
   EV/CE(x)0.721.821.622.672.80
   M Cap / Sales0.551.851.642.672.96
Growth Ratio
   Net Sales Growth(%)7.868.72-0.0620.0713.18
   Core EBITDA Growth(%)3.555.11-17.7142.3419.32
   EBIT Growth(%)-9.9016.39-18.7341.3766.67
   PAT Growth(%)-16.1115.07-27.5049.22254.72
   EPS Growth(%)-16.1115.08-27.5149.18241.03
Financial Stability Ratios
   Total Debt/Equity(x)0.800.800.901.051.10
   Current Ratio(x)1.651.672.132.541.48
   Quick Ratio(x)1.131.111.511.751.08
   Interest Cover(x)3.904.894.927.286.84
   Total Debt/Mcap(x)0.840.240.310.200.18

Directory

current IPO
  • --
upcoming IPO
Narnolia Research & Advisory Narnolia Online | media Room